Last Price
0.03
Today's Change
-0.003 (9.09%)
Day's Change
0.03 - 0.032
Trading Volume
2,506,205
Profile
LDX
Exchange: Australian Securities Exchange Australian Securities Exchange
Currency: AUD AUD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Douglas Ward Mr. Douglas Ward
Full Time Employees: 0 0
IPO Date: 2021-07-05 2021-07-05
ISIN: AU0000157091 AU0000157091
Beta: 0.78 0.78
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
Description
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australia raised Fair Trade in Trump Phone Call, Says PM Albanese
2
CEO Morning Brief
Australia Faces Economic Pain From Trump Win, Treasurer Warns
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
